▶ 調査レポート

世界の凍結手術装置市場2022年-2027年:成長・動向・新型コロナの影響・市場予測

• 英文タイトル:Cryosurgery Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Mordor Intelligenceが調査・発行した産業分析レポートです。世界の凍結手術装置市場2022年-2027年:成長・動向・新型コロナの影響・市場予測 / Cryosurgery Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) / MRC2203A375資料のイメージです。• レポートコード:MRC2203A375
• 出版社/出版日:Mordor Intelligence / 2022年1月
• レポート形態:英文、PDF、110ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥703,000 (USD4,750)▷ お問い合わせ
  Site Licence¥962,000 (USD6,500)▷ お問い合わせ
  Corporate License¥1,295,000 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Mordor Intelligence社の本市場調査レポートでは、世界の凍結手術装置市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品種類別(組織接触プローブ、ティッシュスプレープローブ、表皮・皮下冷凍アブレーション装置)分析、用途別(手術、疼痛管理、回復・健康・美容)分析、エンドユーザー別(病院、凍結療法センター)分析、地域別(北米、ヨーロッパ、アジア太平洋、その他地域)分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界の凍結手術装置市場規模:製品種類別(組織接触プローブ、ティッシュスプレープローブ、表皮・皮下冷凍アブレーション装置)
・世界の凍結手術装置市場規模:用途別(手術、疼痛管理、回復・健康・美容)
・世界の凍結手術装置市場規模:エンドユーザー別(病院、凍結療法センター)
・世界の凍結手術装置市場規模:地域別(北米、ヨーロッパ、アジア太平洋、その他地域)
・競争状況(ArtiCure Inc.、Bovie、Brymill Cryogenic Systems、…)
・市場機会・将来傾向

The cryosurgery devices market is expected to register a boost in its growth rate, due to increasing disorders, such as cardiovascular diseases and skin disorders. According to the World Health Organization, cardiovascular diseases are the leading cause of death, causing around 17.9 million death around the world.

Key Highlights

  • Furthermore, according to the data of Health and Safety Executive, in 2018, around 67 new cases had been reported with work-related skin cancer in the United Kingdom. Hence, this emerges the need for treatment for these diseases.
  • Also, development in cryosurgery devices is expected to boost the market. In 2019, CSA Medical Inc. received European approval to market its product ‘Rejuven Air System’. It is a cryosurgical device that involves Metred Cryospray (liquid nitrogen) for the treatment of chronic bronchitis through bronchoscopic surgery. Thus, these factors are expected to boost the growth of the cryosurgery devices market.

Key Market Trends

Oncology Disorder Segment is Expected to Hold a Major Share in the Cryosurgery Devices Market

The oncology segment is expected to hold a major share in the cryosurgery devices market, owing to the higher prevalence of cancer and rising preference towards minimally invasive surgery. According to the World Health Organization, the burden of cancer in 2018 was around 18.1 million cases globally. It is the second leading cause of death worldwide, causing around 9.6 million deaths according to the above-mentioned source.

Furthermore, cryoablation has been observed to be very effective in the treatment of breast carcinomas over the percutaneous ablation method. According to the World Health Organization, in 2018, lung and breast cancers are the most prevalent, and approximately 2.1 million had been diagnosed with it. Therefore, the aforementioned factors are expected to impact positively on the cryosurgery devices market.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region for the studied market, owing to the increasing burden of chronic disorders and the presence of product approvals. According to the National Cancer Institutes, in 2018, approximately 1.74 million had been diagnosed with cancer in the United States. Furthermore, in 2019, the US FDA approved two cryosurgical devices ‘ CryoTouch’ and ‘CryoLab’ developed by Cryoconcepts. Cryotouch is a portable device that delivers cryogen to the targeted lesions while the cryolab has been involved in high volume surgeries. These have been approved for 23 indications. Hence, such factors are expected to drive the cryosurgery market in North America.

Competitive Landscape

Some of the companies that are currently dominating the market are Harvard Bioscience Inc., AtriCure Inc., Brymill Cryogenic Systems, Cardinal Health, CryoConcepts, Cortex Technology, Bovie, and Cooper Surgical.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
レポート目次

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Chronic Diseases
4.2.2 Rising Preference for Minimally Invasive Surgeries
4.3 Market Restraints
4.3.1 Stringent Regulatory Guidelines and Reimbursement Issues
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Tissue Contact Probes
5.1.2 Tissue Spray Probes
5.1.3 Epidermal and Subcutaneous Cryoablation Devices
5.2 By Application
5.2.1 Surgeries
5.2.1.1 Oncology
5.2.1.2 Cardiology
5.2.1.3 Dermatology
5.2.1.4 Other Applications
5.2.2 Pain Management
5.2.3 Recovery, Health, and Beauty
5.3 By End User
5.3.1 Hospital
5.3.2 Cryotherapy Center
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Rest of the World

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 ArtiCure Inc.
6.1.2 Bovie
6.1.3 Brymill Cryogenic Systems
6.1.4 BVM Medical
6.1.5 Cardinal Health
6.1.6 CryoConcepts
6.1.7 Cortex Technology
6.1.8 Cooper Surgical
6.1.9 Harvard Bioscience Inc.
6.1.10 Premier Medical Co.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS